CoChat

Abnormalities in brain structure and biochemistry associated with mdx mice measured by in vivo MRI and high resolution localized 1H MRS

Xu, Su, Shi, Da, Pratt, Stephen J.P., Zhu, Wenjun, Marshall, Andrew, Lovering, Richard M. · 2015 · Neuromuscular Disorders
Cited by 24

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nmd.2015.07.003

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 82

  1. McDonald, 1995, Profiles of neuromuscular diseases. Duchenne muscular dystrophy, Am J Phys Med Rehabil, 74, S70, 10.1097/00002060-199509001-00003 · DOI · Paper page
  2. Brooke, 1989, Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy, Neurology, 39, 475, 10.1212/WNL.39.4.475 · DOI · Paper page
  3. Lovering, 2005, The muscular dystrophies: from genes to therapies, Phys Ther, 85, 1372, 10.1093/ptj/85.12.1372 · DOI
  4. Tinsley, 1994, Increasing complexity of the dystrophin-associated protein complex, Proc Natl Acad Sci U S A, 91, 8307, 10.1073/pnas.91.18.8307 · DOI · Paper page
  5. Blake, 1996, Utrophin: a structural and functional comparison to dystrophin, Brain Pathol, 6, 37, 10.1111/j.1750-3639.1996.tb00781.x · DOI · Paper page
  6. Anderson, 2002, Brain function in Duchenne muscular dystrophy, Brain, 125, 4, 10.1093/brain/awf012 · DOI · Paper page
  7. Nardes, 2012, Mental retardation in Duchenne muscular dystrophy, J Pediatr (Rio J), 88, 6, 10.2223/JPED.2148 · DOI
  8. Cotton, 2005, Association between intellectual functioning and age in children and young adults with Duchenne muscular dystrophy: further results from a meta-analysis, Dev Med Child Neurol, 47, 257, 10.1017/S0012162205000496 · doi:10.1017/s0012162205000496
  9. Hinton, 2007, Verbal and memory skills in males with Duchenne muscular dystrophy, Dev Med Child Neurol, 49, 123, 10.1111/j.1469-8749.2007.00123.x · DOI
  10. Wingeier, 2011, Neuropsychological impairments and the impact of dystrophin mutations on general cognitive functioning of patients with Duchenne muscular dystrophy, J Clin Neurosci, 18, 90, 10.1016/j.jocn.2010.07.118 · DOI
  11. Cotton, 2001, Intelligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients, Dev Med Child Neurol, 43, 497
  12. Wicksell, 2004, Specific cognitive deficits are common in children with Duchenne muscular dystrophy, Dev Med Child Neurol, 46, 154, 10.1111/j.1469-8749.2004.tb00466.x · DOI
  13. Marini, 2007, Evaluation of narrative abilities in patients suffering from duchenne muscular dystrophy, Brain Lang, 102, 1, 10.1016/j.bandl.2007.02.003 · DOI
  14. Muntoni, 1991, Passive avoidance behaviour deficit in the mdx mouse, Neuromuscul Disord, 1, 121, 10.1016/0960-8966(91)90059-2 · DOI · Paper page
  15. Perronnet, 2012, Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice, Hum Mol Genet, 21, 2263, 10.1093/hmg/dds047 · DOI
  16. Yoshioka, 1980, Central nervous system involvement in progressive muscular dystrophy, Arch Dis Child, 55, 589, 10.1136/adc.55.8.589 · DOI · Paper page
  17. Chen, 1999, A novel deletion of the dystrophin S-promoter region cosegregating with mental retardation, Neurology, 52, 638, 10.1212/WNL.52.3.638 · doi:10.1212/wnl.52.3.638
  18. Rae, 1998, Brain biochemistry in Duchenne muscular dystrophy: a 1H magnetic resonance and neuropsychological study, J Neurol Sci, 160, 148, 10.1016/S0022-510X(98)00190-7 · DOI · Paper page
  19. Kreis, 2011, Brain metabolite composition in relation to cognitive function and dystrophin mutations in boys with Duchenne muscular dystrophy, NMR Biomed, 24, 253, 10.1002/nbm.1582 · DOI · Paper page
  20. Tracey, 1996, An in vivo and in vitro H-magnetic resonance spectroscopy study of mdx mouse brain: abnormal development or neural necrosis?, J Neurol Sci, 141, 13, 10.1016/0022-510X(96)00135-9 · DOI
  21. Cyrulnik, 2008, Duchenne muscular dystrophy: a cerebellar disorder?, Neurosci Biobehav Rev, 32, 486, 10.1016/j.neubiorev.2007.09.001 · DOI
  22. Tracey, 1996, Brain metabolism is abnormal in the mdx model of Duchenne muscular dystrophy, Brain, 119, 1039, 10.1093/brain/119.3.1039 · DOI · Paper page
  23. Uchino, 1994, Dystrophin and dystrophin-related protein in the brains of normal and mdx mice, Muscle Nerve, 17, 533, 10.1002/mus.880170511 · DOI
  24. Koenig, 1988, The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein, Cell, 53, 219, 10.1016/0092-8674(88)90383-2 · DOI · Paper page
  25. Lansman, 1991, What does dystrophin do in normal muscle?, J Muscle Res Cell Motil, 12, 409, 10.1007/BF01738325 · DOI
  26. Lovering, 2009, Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling, Am J Physiol Cell Physiol, 297, C571, 10.1152/ajpcell.00087.2009 · DOI
  27. Gee, 1998, Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins, J Neurosci, 18, 128, 10.1523/JNEUROSCI.18-01-00128.1998 · DOI · Paper page
  28. Kong, 1999, Dystrophin is required for organizing large acetylcholine receptor aggregates, Brain Res, 839, 298, 10.1016/S0006-8993(99)01737-0 · DOI
  29. Pratt, 2013, Effects of in vivo injury on the neuromuscular junction in healthy and dystrophic muscles, J Physiol, 591, 559, 10.1113/jphysiol.2012.241679 · DOI
  30. Khairallah, 2012, Microtubules underlie dysfunction in duchenne muscular dystrophy, Sci Signal, 5, ra56, 10.1126/scisignal.2002829 · DOI · Paper page
  31. Whitehead, 2006, Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species, Clin Exp Pharmacol Physiol, 33, 657, 10.1111/j.1440-1681.2006.04394.x · DOI · Paper page
  32. Xu, 2013, In vivo high-resolution localized (1) H MR spectroscopy in the awake rat brain at 7 T, Magn Reson Med, 69, 937, 10.1002/mrm.24321 · DOI
  33. Provencher, 2001, Automatic quantitation of localized in vivo 1H spectra with LCModel, NMR Biomed, 14, 260, 10.1002/nbm.698 · DOI · Paper page
  34. Zhuo, 2012, Diffusion kurtosis as an in vivo imaging marker for reactive astrogliosis in traumatic brain injury, Neuroimage, 59, 467, 10.1016/j.neuroimage.2011.07.050 · DOI · Paper page
  35. Golmohammadi, 2008, Comparative analysis of the frequency and distribution of stem and progenitor cells in the adult mouse brain, Stem Cells, 26, 979, 10.1634/stemcells.2007-0919 · DOI · Paper page
  36. Petrof, 2002, Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex, Am J Phys Med Rehabil, 81, S162, 10.1097/00002060-200211001-00017 · DOI
  37. Rando, 2001, The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies, Muscle Nerve, 24, 1575, 10.1002/mus.1192 · DOI · Paper page
  38. Muntoni, 2003, Dystrophin and mutations: one gene, several proteins, multiple phenotypes, Lancet Neurol, 2, 731, 10.1016/S1474-4422(03)00585-4 · DOI · Paper page
  39. Garcia-Tovar, 2001, Biochemical and histochemical analysis of 71 kDa dystrophin isoform (Dp71f) in rat brain, Acta Histochem, 103, 209, 10.1078/0065-1281-00591 · DOI
  40. Daoud, 2009, Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression, Hum Mol Genet, 18, 3779, 10.1093/hmg/ddp320 · DOI
  41. Moizard, 2000, Severe cognitive impairment in DMD: obvious clinical indication for Dp71 isoform point mutation screening, Eur J Hum Genet, 8, 552, 10.1038/sj.ejhg.5200488 · DOI
  42. Taylor, 2010, Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy, PLoS ONE, 5, e8803, 10.1371/journal.pone.0008803 · DOI · Paper page
  43. Lenk, 1993, Point mutations at the carboxy terminus of the human dystrophin gene: implications for an association with mental retardation in DMD patients, Hum Mol Genet, 2, 1877, 10.1093/hmg/2.11.1877 · DOI
  44. Culligan, 2002, Diversity of the brain dystrophin-glycoprotein complex, J Biomed Biotechnol, 2, 31
  45. Lidov, 1990, Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons, Nature, 348, 725, 10.1038/348725a0 · DOI · Paper page
  46. Kim, 1992, Detection of dystrophin in the postsynaptic density of rat brain and deficiency in a mouse model of Duchenne muscular dystrophy, Proc Natl Acad Sci U S A, 89, 11642, 10.1073/pnas.89.23.11642 · DOI · Paper page
  47. Goodnough, 2014, Lack of dystrophin results in abnormal cerebral diffusion and perfusion in vivo, Neuroimage, 102, 809, 10.1016/j.neuroimage.2014.08.053 · DOI · Paper page
  48. Warskulat, 2004, Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised, FASEB J, 18, 577, 10.1096/fj.03-0496fje · DOI · Paper page
  49. Huxtable, 1992, Physiological actions of taurine, Physiol Rev, 72, 101, 10.1152/physrev.1992.72.1.101 · DOI · Paper page
  50. Conte, 2004, Taurine and skeletal muscle disorders, Neurochem Res, 29, 135, 10.1023/B:NERE.0000010442.89826.9c · DOI
  51. Hollingworth, 2008, Comparison of the myoplasmic calcium transient elicited by an action potential in intact fibres of mdx and normal mice, J Physiol, 586, 5063, 10.1113/jphysiol.2008.160507 · DOI
  52. Woods, 2004, The action potential-evoked sarcoplasmic reticulum calcium release is impaired in mdx mouse muscle fibres, J Physiol, 557, 59, 10.1113/jphysiol.2004.061291 · DOI
  53. Yeung, 2005, Effects of stretch-activated channel blockers on [Ca2+]i and muscle damage in the mdx mouse, J Physiol, 562, 367, 10.1113/jphysiol.2004.075275 · DOI · Paper page
  54. Hernandez-Ochoa, 2015, Disruption of action potential and calcium signaling properties in malformed myofibers from dystrophin-deficient mice, Physiol Rep, 3, e12366, 10.14814/phy2.12366 · DOI
  55. Woods, 2005, Propagation in the transverse tubular system and voltage dependence of calcium release in normal and mdx muscle fibres, J Physiol, 568, 867, 10.1113/jphysiol.2005.089318 · DOI
  56. Friedrich, 2008, L-type Ca2+ channel function is linked to dystrophin expression in mammalian muscle, PLoS ONE, 3, e1762, 10.1371/journal.pone.0001762 · DOI
  57. Yeung, 2005, Effects of stretch-activated channel blockers on [Ca2+]i and muscle damage in the mdx mouse, J Physiol, 562, 367, 10.1113/jphysiol.2004.075275 · DOI · Paper page
  58. Kar, 1979, Catalase, superoxide dismutase, glutathione reductase and thiobarbituric acid-reactive products in normal and dystrophic human muscle, Clin Chim Acta, 94, 277, 10.1016/0009-8981(79)90076-7 · DOI
  59. Mizuno, 1984, Changes in superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activities and thiobarbituric acid-reactive products levels in early stages of development in dystrophic chickens, Exp Neurol, 84, 58, 10.1016/0014-4886(84)90006-2 · DOI
  60. Murphy, 1986, Activities of antioxidant enzymes in muscle, liver and lung of chickens with inherited muscular dystrophy, Biochem Biophys Res Commun, 134, 550, 10.1016/S0006-291X(86)80455-7 · doi:10.1016/s0006-291x(86)80455-7
  61. Rae, 2002, Abnormalities in brain biochemistry associated with lack of dystrophin: studies of the mdx mouse, Neuromuscul Disord, 12, 121, 10.1016/S0960-8966(01)00253-X · DOI · Paper page
  62. Kanfer, 1986, Reduced phosphorylcholine hydrolysis by homogenates of temporal regions of Alzheimer's brain, Biochem Biophys Res Commun, 139, 315, 10.1016/S0006-291X(86)80115-2 · doi:10.1016/s0006-291x(86)80115-2
  63. Pettegrew, 1988, 31P nuclear magnetic resonance study of the brain in Alzheimer's disease, J Neuropathol Exp Neurol, 47, 235, 10.1097/00005072-198805000-00004 · DOI · Paper page
  64. Sok, 1999, Oxidative inactivation of brain alkaline phosphatase responsible for hydrolysis of phosphocholine, J Neurochem, 72, 355, 10.1046/j.1471-4159.1999.0720355.x · DOI
  65. Reggiani, 2008, Between channels and tears: aim at ROS to save the membrane of dystrophic fibres, J Physiol, 586, 1779, 10.1113/jphysiol.2008.152629 · doi:10.1113/jphysiol.2008.152629
  66. Knuesel, 1999, Short communication: altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice), Eur J Neurosci, 11, 4457, 10.1046/j.1460-9568.1999.00887.x · DOI · Paper page
  67. Goyenvalle, 2015, Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers, Nat Med, 21, 270, 10.1038/nm.3765 · DOI · Paper page
  68. Chamberlain, 2007, Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma, FASEB J, 21, 2195, 10.1096/fj.06-7353com · DOI · Paper page
  69. Glesby, 1988, Serum CK, calcium, magnesium, and oxidative phosphorylation in mdx mouse muscular dystrophy, Muscle Nerve, 11, 852, 10.1002/mus.880110809 · DOI
  70. Muntoni, 1993, Muscular weakness in the mdx mouse, J Neurol Sci, 120, 71, 10.1016/0022-510X(93)90027-V · DOI
  71. De la, 1999, Characteristics of skeletal muscle in mdx mutant mice, Int Rev Cytol, 191, 99, 10.1016/S0074-7696(08)60158-8 · DOI
  72. Dangain, 1984, Muscle development in mdx mutant mice, Muscle Nerve, 7, 700, 10.1002/mus.880070903 · DOI · Paper page
  73. Dubowitz, 1969, The central nervous system in Duchenne muscular dystrophy, Brain, 92, 805, 10.1093/brain/92.4.805 · DOI · Paper page
  74. Bresolin, 1994, Cognitive impairment in Duchenne muscular dystrophy, Neuromuscul Disord, 4, 359, 10.1016/0960-8966(94)90072-8 · DOI · Paper page
  75. Schmidt, 1985, Increased head circumference in patients with Duchenne muscular dystrophy, Ann Neurol, 17, 620, 10.1002/ana.410170622 · doi:10.1002/ana.410170622
  76. Appleton, 1991, Head circumference and intellectual performance of patients with Duchenne muscular dystrophy, Dev Med Child Neurol, 33, 884, 10.1111/j.1469-8749.1991.tb14797.x · DOI
  77. Rosman, 1966, Mental deficiency associated with muscular dystrophy. A neuropathological study, Brain, 89, 769, 10.1093/brain/89.4.769 · DOI · Paper page
  78. Rosman, 1970, The cerebral defect and myopathy in Duchenne muscular dystrophy. A comparative clinicopathological study, Neurology, 20, 329, 10.1212/WNL.20.4.329 · doi:10.1212/wnl.20.4.329
  79. Septien, 1991, Mental development in Duchenne muscular dystrophy. Correlation of data of the brain scanner], Pediatrie, 46, 817
  80. al-Qudah, 1990, Etiology of intellectual impairment in Duchenne muscular dystrophy, Pediatr Neurol, 6, 57, 10.1016/0887-8994(90)90081-B · DOI · Paper page
  81. Ortiz, 1990, The C57BL/10Bg sps/sps mouse: a mutant with absence-like seizures; neurochemical and behavioral correlates, Neurosci Lett, 114, 231, 10.1016/0304-3940(90)90077-M · doi:10.1016/0304-3940(90)90077-m
  82. Kueh, 2011, Reduced postsynaptic GABAA receptor number and enhanced gaboxadol induced change in holding currents in Purkinje cells of the dystrophin-deficient mdx mouse, Neurobiol Dis, 43, 558, 10.1016/j.nbd.2011.05.002 · DOI

Cited by

See all 24

Metadata

Authors
Xu, S., Shi, D., Pratt, S. J. P., Zhu, W., Marshall, A., & Lovering, R. M.
Venue
Neuromuscular Disorders
Publisher
Elsevier BV
Published
2015-10
Volume
25
Issue
10
Pages
764-772
ISSN
0960-8966
Cited by
24
References
2
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
National Institutes of Health (R01AR059179)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Abnormalities in brain structure and biochemistry associated with mdx mice measured by in vivo MRI and high resolution localized 1H MRS. https://app.cochat.ai/papers/10.1016/j.nmd.2015.07.003
The paper
Xu, S., Shi, D., Pratt, S. J. P., Zhu, W., Marshall, A., & Lovering, R. M. (2015). Abnormalities in brain structure and biochemistry associated with mdx mice measured by in vivo MRI and high resolution localized 1H MRS. Neuromuscular Disorders. https://doi.org/10.1016/j.nmd.2015.07.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.